Ethambutol: all 30 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Re-evaluating the Duration in Children of TB TreatmentNot yet recruitingNCT07656012Phase 2
- Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)Not yet recruitingNCT07163143Phase 3
- PanACEA - STEP2C -01RecruitingNCT05807399Phase 2
- Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With TuberculosisTerminatedNCT06041919Phase 2Results posted
- Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary TuberculosisTerminatedNCT05971602Phase 2Results posted
- Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary TuberculosisCompletedNCT05382312Phase 2Results posted
- Using Biomarkers to Predict TB Treatment DurationCompletedNCT02821832Phase 2Results posted
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of TuberculosisCompletedNCT02563327Phase 3Results posted
- The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TBCompletedNCT02409290Phase 3Results posted
- Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary SarcoidosisCompletedNCT02024555Phase 2Results posted
- REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentCompletedNCT01380080Phase 4Results posted
- Effect of Weight and/or Obesity on Ethambutol Drug ConcentrationsCompletedNCT01048697Phase 4Results posted
- Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisCompletedNCT00864383Phase 3Results posted
- Tuberculosis Treatment Shortening TrialCompletedNCT00130247Phase 3Results posted
- A Study to Evaluate the Effect of Co-administration on the Pharmacokinetics of SPR720, Azithromycin, and Ethambutol in Healthy ParticipantsCompletedNCT05966688Phase 1
- Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated TuberculosisActive, not recruitingNCT04951986Phase 3
- Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and PyrazinamideSuspendedNCT04694586Phase 2
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive TuberculosisCompletedNCT03474198Phase 2/3
- The Optimal Duration of Preoperative Anti-tuberculosis Treatment of Spinal TuberculosisStatus unknownNCT02477852Phase 4
- PK Study of Anti-TB DrugsCompletedNCT02457208Phase 1
- Research on New Regimens for Retreatment Pulmonary TuberculosisStatus unknownNCT02331823Phase 4
- Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesStatus unknownNCT01782950Phase 4
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated TuberculosisCompletedNCT00698334Phase 3
- Preventive Therapy for Tuberculosis in HIV Infected PersonsCompletedNCT00351702Phase 3
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or IntoleranceCompletedNCT00023374Not applicable
- A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDSCompletedNCT00002343Phase 4
- The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDSCompletedNCT00002331Not applicable
- A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs PatientsCompletedNCT00002140Phase 3
- A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or PlaceboCompletedNCT00002101Phase 3
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedNCT00000641Phase 2